Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Remus Pharmaceuticals Ltd

NSE: REMUS · Pharmaceuticals & Biotechnology · 18 announcements

Share price
₹860.15
Market cap
₹1,014 Cr
Revenue (annual)
₹853.6 Cr
Net profit (annual)
₹36.99 Cr
P/E (TTM)
27.4×Sector 47.4×
Promoter holding
70.95%
FII holding
5.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

21:00 IST NSE
Dividend

Remus Pharmaceuticals Dividend

Remus Pharmaceuticals Limited has fixed September 22, 2026, as the record date for determining shareholder entitlement to a final dividend of Rs. 0.50 per share.

15:21 IST NSE
Dividend

Remus Pharmaceuticals Dividend

Remus Pharmaceuticals recommended a final dividend of Rs. 0.50 per equity share for 2026. The record date will be announced later following shareholder approval.

Value
₹0.50 Cr